Closed
Early Stage Commercialization Fund (ESCF)
Funding for early-stage research commercialization
Last Update: April 29, 2026
Funding available
$ 50,000
Timeline
- Open Date : January 5, 2026
- Closing date : February 9, 2026
Location
Nova Scotia, Canada
Overview
The Early Stage Commercialization Fund supports Nova Scotia research projects moving toward market readiness. Up to $50,000 CAD per project is available for activities such as intellectual property development, prototype or proof-of-concept work, market assessment, business planning, and go-to-market strategy development.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Develop a new product or service
- Conduct research and development activities
Eligible Funding
- Maximum amount : 50,000 $
- Up to 100% of project cost
Timeline
- Open Date : January 5, 2026
- Closing date : February 9, 2026
Eligible candidates
Eligible Industries
- Professional, scientific and technical services
- Educational services
- Health care and social assistance
Location
- Nova Scotia
Legal structures
- Public or Parapublic institution
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Canadians
- Startups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Technology transfer and commercialization projects
- Market assessment and go-to-market planning
- Proof-of-concept and prototype development
- Intellectual property development and protection planning
- Pre-clinical testing and clinical validation
Documents Needed
- Completed proposal form
- CV of the principal investigator(s)
- Final Phase One report, for Phase Two applicants
Eligibility
Who is eligible?
- Nova Scotia university faculty and staff
- Clinicians and researchers in university-affiliated institutions
- Graduate students and post-docs with a faculty co-applicant
Who is not eligible
- Invest Nova Scotia portfolio companies
- Current or past Accelerate program companies
Eligible expenses
- Labour, direct materials, and direct project expenses
- Business consulting and legal costs, with limits
- Patent-related costs, up to 10% of the request
- Prototype, proof-of-concept, and pre-clinical or clinical validation costs
Ineligible Costs and Activities
- Overhead and administration costs
- General equipment and other hard-to-attribute costs
- Website creation, marketing materials, and conferences, generally
- Principal investigator costs for proof-of-concept or prototype development
Eligible geographic areas
- Nova Scotia
Processing and Agreement
- Applications are reviewed after submission through the online portal.
- Shortlisted applicants are notified before the next review stage.
- Shortlisted researchers meet with the evaluation committee.
- Successful applicants are notified after the review process.
Additional information
- No application fee is charged.
- Approved applicants must agree to public announcement and disclosure of project information.
- Quarterly progress meetings are required during the project.
- Failure to submit required reports may affect future applications from affiliated institutions.
Contacts
Frequently Asked Questions about the Early Stage Commercialization Fund (ESCF) Program
Here are answers to the most common questions about the Early Stage Commercialization Fund (ESCF). This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Early Stage Commercialization Fund (ESCF)?
The Early Stage Commercialization Fund supports Nova Scotia research projects moving toward market readiness. Up to $50,000 CAD per project is available for activities such as intellectual property development, prototype or proof-of-concept work, market assessment, business planning, and go-to-market strategy development.
How much funding can be received?
Early Stage Commercialization Fund (ESCF) Funds up to 100% of admissible expenses, capped at $50,000 per project.
What is the deadline to apply?
The application deadline for this grant program was February 9, 2026.
Who is eligible for the Early Stage Commercialization Fund (ESCF) program?
To be eligible for the Early Stage Commercialization Fund (ESCF) program, you must:
Nova Scotia academic or affiliated research
Commercialization-ready technology project
Faculty-led application
What expenses are eligible under Early Stage Commercialization Fund (ESCF)?
Technology transfer and commercialization projects
Market assessment and go-to-market planning
Proof-of-concept and prototype development
Intellectual property development and protection planning
Pre-clinical testing and clinical validation
Who can I contact for more information about the Early Stage Commercialization Fund (ESCF)?
You can contact Invest Nova Scotia by email at grant.ruffinengo@investnovascotia.ca or by phone at 782.641.1240.
Where is the Early Stage Commercialization Fund (ESCF) available?
The Early Stage Commercialization Fund (ESCF) program is available the province of Nova Scotia.